Latham & Watkins represented Agenus Inc. in the transaction. Agenus Inc. (Agenus), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here